For a while now CBD has been dominating the spotlight and getting all the attention, but major players in the cannabis, hemp, and legal CBD industries are suggesting that minor cannabinoids might become even more desirable than CBD among consumers looking for unique health benefits. This is because of the increased benefits being observed in full spectrum and broad-spectrum CBD products containing not only CBD but a host of minor cannabinoids as well which when combined contribute to a more pronounced entourage effect.
The lure of CBD for many is that it is nonintoxicating. Many minor cannabinoids are nonintoxicating as well and can be used in the same ways CBD is being used including topicals, edibles, beverages and of course concentrates and smokable flower.
Studies have found minor cannabinoids to:
• Relieve ailments caused by immune disorders (CBG)
• Reduce epileptiform activity associated with seizures (CBDV)
• Promote rest (CBN)
• Reduce pain and inflammation (CBC)
The FDA prevents us from making any claims or going into the medical benefits of minor cannabinoids in any great detail, but a quick google search for any of the several minor cannabinoids present in cannabis and hemp will yield pages of results discussing the numerous benefits that have been found thus far.
Considering the fact that so many benefits have been found and attributed to these cannabinoids in the short period in which they have been studied, it is almost certain that we will see many more benefits discovered and revealed by researchers in the future.